BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $14.19 billion. The enterprise value is $15.40 billion.

Market Cap	14.19B
Enterprise Value	15.40B

Important Dates

The last earnings date was Wednesday, October 29, 2025, after market close.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

BBIO has 192.71 million shares outstanding. The number of shares has increased by 4.48% in one year.

Current Share Class	192.71M
Shares Outstanding	192.71M
Shares Change (YoY)	+4.48%
Shares Change (QoQ)	+0.70%
Owned by Insiders (%)	4.29%
Owned by Institutions (%)	83.00%
Float	155.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.65
Forward PS	18.98
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	43.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.88

Current Ratio	3.88
Quick Ratio	3.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-43.47%
Return on Invested Capital (ROIC)	-161.27%
Return on Capital Employed (ROCE)	-74.01%
Revenue Per Employee	$484,630
Profits Per Employee	-$1.09M
Employee Count	730
Asset Turnover	0.43
Inventory Turnover	n/a

Taxes

In the past 12 months, BBIO has paid $1.71 million in taxes.

Income Tax	1.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +171.73% in the last 52 weeks. The beta is 1.26, so BBIO's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	+171.73%
50-Day Moving Average	61.58
200-Day Moving Average	46.11
Relative Strength Index (RSI)	70.13
Average Volume (20 Days)	2,112,993

Short Selling Information

The latest short interest is 20.69 million, so 10.74% of the outstanding shares have been sold short.

Short Interest	20.69M
Short Previous Month	19.57M
Short % of Shares Out	10.74%
Short % of Float	13.33%
Short Ratio (days to cover)	8.04

Income Statement

In the last 12 months, BBIO had revenue of $353.78 million and -$797.12 million in losses. Loss per share was -$4.18.

Revenue	353.78M
Gross Profit	338.84M
Operating Income	-578.47M
Pretax Income	-803.98M
Net Income	-797.12M
EBITDA	-573.10M
EBIT	-578.47M
Loss Per Share	-$4.18

Full Income Statement

Balance Sheet

The company has $645.94 million in cash and $1.86 billion in debt, giving a net cash position of -$1.21 billion or -$6.30 per share.

Cash & Cash Equivalents	645.94M
Total Debt	1.86B
Net Cash	-1.21B
Net Cash Per Share	-$6.30
Equity (Book Value)	-1.92B
Book Value Per Share	-10.03
Working Capital	622.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$584.82 million and capital expenditures -$1.11 million, giving a free cash flow of -$585.93 million.

Operating Cash Flow	-584.82M
Capital Expenditures	-1.11M
Free Cash Flow	-585.93M
FCF Per Share	-$3.04

Full Cash Flow Statement

Margins

Gross margin is 95.78%, with operating and profit margins of -163.51% and -225.31%.

Gross Margin	95.78%
Operating Margin	-163.51%
Pretax Margin	-227.26%
Profit Margin	-225.31%
EBITDA Margin	-161.99%
EBIT Margin	-163.51%
FCF Margin	n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.48%
Shareholder Yield	-4.48%
Earnings Yield	-5.62%
FCF Yield	-4.13%

Dividend Details

Analyst Forecast

The average price target for BBIO is $74.79, which is 1.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$74.79
Price Target Difference	1.56%
Analyst Consensus	Strong Buy
Analyst Count	19
Revenue Growth Forecast (5Y)	59.84%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BBIO has an Altman Z-Score of -4.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.49
Piotroski F-Score	3